Saudi - Delayed Quote SAR

Dr. Soliman Abdel Kader Fakeeh (4017.SR)

46.35
-0.35
(-0.75%)
At close: 3:15:18 PM GMT+3
Loading Chart for 4017.SR
  • Previous Close 46.70
  • Open 47.00
  • Bid 46.45 x --
  • Ask 46.40 x --
  • Day's Range 46.00 - 47.15
  • 52 Week Range 43.20 - 72.90
  • Volume 588,380
  • Avg. Volume 552,591
  • Market Cap (intraday) 10.66B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 57.02

Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It operates through Medical Services; Education; and Trading, Retail & Others segments. The company offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, lasik surgery, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pediatric orthopedic surgery, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery, as well as pain treatment and palliative care services. It also operates AIRS, anesthesia, burn, diagnostics service, emergency medicine, endoscopy, intensive care, NICU, renal dialysis, rhinoplasty, and institute of robotic surgery facilities; establishes and manages pharmacies; and provides analysis and radiology laboratory, healthcare, medical education, and home health care services. In addition, the company engages in the trading of pharmaceutical products, spectacles, and cosmetics; construction and contracting; wholesale and retail of medical equipment; and maintenance of IT equipment and software related services. The company was incorporated in 1978 and is based in Jeddah, the Kingdom of Saudi Arabia.

dsfhjeddah.fakeeh.care

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4017.SR

View More

Performance Overview: 4017.SR

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .

YTD Return

4017.SR
30.82%
Tadawul All Shares Index (^TASI.SR)
4.19%

1-Year Return

4017.SR
26.66%
Tadawul All Shares Index (^TASI.SR)
4.86%

3-Year Return

4017.SR
26.66%
Tadawul All Shares Index (^TASI.SR)
10.15%

5-Year Return

4017.SR
26.66%
Tadawul All Shares Index (^TASI.SR)
71.68%

Compare To: 4017.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4017.SR

View More

Valuation Measures

Annual
As of 5/13/2025
  • Market Cap

    10.74B

  • Enterprise Value

    11.04B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.30%

  • Return on Assets (ttm)

    4.70%

  • Return on Equity (ttm)

    11.53%

  • Revenue (ttm)

    2.79B

  • Net Income Avi to Common (ttm)

    287.55M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    533.78M

  • Total Debt/Equity (mrq)

    32.47%

  • Levered Free Cash Flow (ttm)

    -129.39M

Research Analysis: 4017.SR

View More

Company Insights: 4017.SR

Research Reports: 4017.SR

View More

People Also Watch